Clinical impact of additional therapy for residual pancreatic cancer
Sign Up to like & getrecommendations! Published in 2019 at "Surgery Today"
DOI: 10.1007/s00595-019-01900-y
Abstract: Purpose This study aimed to explore the prognostic significance of the resection margin (R) status of pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant therapy (NAT) or adjuvant chemotherapy (AC). Methods We retrospectively reviewed 427 consecutive… read more here.
Keywords: therapy; nat group; clinical impact; resection ... See more keywords